Getty Images
Industryweek 12466 Theranos Ceo Elizabeth Holmes

Theranos Sued by Venture Capitalist for Misrepresentation

Nov. 28, 2016
The lawsuit argues CEO Elizabeth Holmes’s claims were overstated and the technology was flawed. 

Theranos Inc. was sued by a venture capital investor over claims Chief Executive Officer Elizabeth Holmes lied about the company’s blood laboratory technology in which a pinprick of blood could be tested for hundreds of diseases.

The lawsuit, citing investigations by the U.S. Justice Department and the Securities and Exchange Commission, argues Holmes’s claims were overstated and the technology was flawed.

The lawsuit seeks class-action status representing investors in Theranos securities from July 29, 2013, to Oct. 2 of this year. The plaintiffs include Robert Colman, who purchased his shares through Menlo Park-based Lucas Venture Group XI LLC, according to the complaint.

Patrick Ryan, a spokesman for Theranos at Hill+Knowlton Strategies, didn’t immediately respond to a request seeking comment on the lawsuit.

Popular Sponsored Recommendations

What Does Agility Look Like for Today's Auto Industry?

Dec. 4, 2023
Without modern technologies, enterprises aren't able to fully analyze the risks and respond to ongoing supply chain issues and semiconductor shortages.

Disruptive EV Technologies Are Driving New Supplier Realities

Sept. 20, 2023
Vehicle electrification is upending the automotive landscape, forcing suppliers to make critical strategic and operational decisions. Understand what that means for you in our...

Food and Beverage 2024 Trends and Outlook for North America

Oct. 29, 2023
Ready to hear what 200 of your peers said are the top challenges and opportunities in 2024? Don’t fall behind. Uncover actionable insights to better prepare for 2024 in this whitepaper...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!